CARDIOPROLIFIC
CardioProlific is develops catheter-based thrombectomy approaches to treat peripheral vascular disease.
CARDIOPROLIFIC
Industry:
Health Care Medical Device
Founded:
2010-01-01
Address:
Hayward, California, United States
Country:
United States
Status:
Active
Contact:
(650) 430-2045
Similar Organizations
Ardian
Ardian is a developer of a catheter-based medical device to treat hypertension.
More informations about "CardioProlific"
CardioProlific - Crunchbase Company Profile & Funding
Organization. CardioProlific . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. CardioProlific is develops catheter-based thrombectomy approaches to treat peripheral vascular disease. Acquired by . ... CardioProlific is located in Hayward, …See details»
CardioProlific Company Profile 2024: Valuation, Investors
CardioProlific General Information Description. Developer of catheter-based thrombectomy system intended to treat peripheral vascular disease. The company's catheter-based …See details»
CardioProlific - Products, Competitors, Financials, Employees ...
CardioProlific is a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Use the CB Insights Platform …See details»
Philips Continues Acquisition Spree, Buys CardioProlific - Yahoo …
Jun 30, 2017 The CardioProlific buyout marks the company’s sixth acquisition this year. The company earlier announced deals to acquire Spectranetics Corporation, Electrical Geodesics, …See details»
Philips acquires CardioProlific - 2017-06-29 - Crunchbase
Jun 29, 2017 CardioProlific CardioProlific is develops catheter-based thrombectomy approaches to treat peripheral vascular disease. Acquiring Organization: Philips Philips is a technology …See details»
CardioProlific Inc - Company Profile and News - Bloomberg Markets
Company profile page for CardioProlific Inc including stock price, company news, executives, board members, and contact informationSee details»
Philips acquires CardioProlific - Vascular News
Jun 29, 2017 Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial …See details»
Royal Philips Acquires CardioProlific - Endovascular Today
Jun 29, 2017 The development of CardioProlific’s differentiated thrombectomy technologies will combine with Philip's suite of image-guided therapy solutions to address the treatment of …See details»
CardioProlific - Crunchbase
CardioProlific is develops catheter-based thrombectomy approaches to treat peripheral vascular disease.See details»
CardioProlific Inc. | TREA
Explore innovation relationships and map ideas to the unified knowledge graphSee details»
Philips expands technology leadership in image-guided therapy …
Press Release | June 29, 2017 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced the acquisition of CardioProlific …See details»
Philips Expands Technology Leadership In Image-Guided Therapy …
Jun 29, 2017 CardioProlific’s technologies are complementary to Philips’ portfolio of image-guided therapy devices and to the portfolio of The Spectranetrics Corporation, which Philips …See details»
Philips buys catheter developer CardioProlific - AuntMinnie
Jun 29, 2017 Royal Philips, the parent company of Philips Healthcare, said it has acquired CardioProlific, a U.S.-based firm that is developing catheter-based thrombectomy products to …See details»
Philips picks up peripheral thrombectomy device maker …
Jul 5, 2017 Philips said the deal for Hayward, Calif.-based CardioProlific is complementary to its $2.16 billion acquisition of Spectranetics (NSDQ:SPNC) and its own line of image-guided …See details»
The Top Cardiovascular CROs: A Comprehensive Ranking of …
Nov 1, 2024 In order to determine the top cardiovascular CROs, several key criteria were taken into consideration. These criteria encompassed both the expertise and capabilities of the …See details»
Local Ultrasound to Enhance Paclitaxel Delivery After Femoral
Oct 24, 2016 Methods: This single-center, single-blind, randomized trial included 56 patients with CLI randomly assigned to treatment in 2 groups: 28 patients (the control group) were …See details»
Canadian Cardiovascular Society
The Canadian Cardiovascular Society is the national voice for cardiovascular clinicians & scientists, representing more than 2,300 cardiologists, cardiac surgeons and other heart health …See details»
The Role of Congenital Heart Disease Patient Organizations in …
Currently, there are over 80 patient organizations serving patients with CHD around the world, and close to 60 from 40 countries belong to the Global Alliance for Rheumatic & Congenital …See details»
The 2020 Canadian Cardiovascular Society/Canadian Heart …
Oct 22, 2020 The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as well …See details»
Leading cardiovascular organizations call for global action to …
WASHINGTON/GENEVA (13 July 2021) — Clinician well-being is imperative to providing high-quality patient care, yet clinician burnout continues to increase, especially over the last year …See details»